Clinical Trial Update: Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the benefits of IL-4 receptor alpha inhibition for aspirin-exacerbated respiratory disease, including asthma and nasal polyps, sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspirin-exacerbated Respiratory Disease
• Asthma
• Nasal Polyps

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Nasal Polyps, Asthma, Aspirin-Induced | Phase 2 | Status: ACTIVE_NOT_RECRUITING